South Korean authorities are scrutinizing a series of financial transactions involving DHX Co., Ltd. And a troubled investment firm, BF Labs, amid concerns over potential irregularities and a delayed capital raise. The situation centers on a planned 5 billion won ($3.8 million USD) investment into DHX by a newly formed entity, raising questions about the true beneficiaries and the ultimate apply of funds. The unfolding events highlight the risks inherent in investments involving companies with opaque structures and a history of financial difficulties.
DHX, formerly known as NSN and Suyu Holdings, has been attempting to secure the capital injection through a rights offering, but the process has been repeatedly delayed, initially slated for the end of last year and now pushed to February 27, 2026. The prospective investor, a company called Preedicom, has raised eyebrows due to its limited public profile and unusual registration details. Established in 2024, Preedicom lists its address as a two-person shared office space in Seoul’s Gangnam district, and attempts to contact representatives have been unsuccessful, according to reporting by Seoul Economic TV.
The planned investment comes as DHX intends to acquire real estate from BF Labs, a company currently suspended from trading on the KOSDAQ market. DHX announced plans last year to purchase land and buildings in Anyang, Gyeonggi Province, totaling 14.5 billion won ($11.1 million USD), which serve as BF Labs’ headquarters. A down payment of approximately 10 billion won ($7.6 million USD) was made in July 2025 through the issuance of convertible bonds (CBs). The issuance of these CBs was similarly subject to delays, prompting speculation that the real estate transaction was used to circumvent regulatory scrutiny.
Further complicating matters, the initial scale of the CB issuance—originally 10 billion won each for the 32nd and 33rd series—was reduced to 5.01 billion won each. This adjustment, according to reports, appears to have been strategically made to avoid being designated as an “unfaithful disclosure” company under KOSDAQ regulations, which are triggered when a company alters its initial fundraising target by more than 50%.
The final payment of 40 billion won ($30.6 million USD) for the property, initially scheduled for September 2025, was postponed to February 22, 2026, and then again to coincide with the planned capital injection from Preedicom on February 27, 2026. This timing has fueled concerns that the funds raised through the rights offering will be immediately used to complete the real estate purchase, effectively channeling a significant amount of capital outside of DHX.
Adding another layer of complexity, DHX recently appointed Cho Young-jung, a former CEO of BF Labs, as a director and co-representative of the company. Cho served as BF Labs’ representative from 2020 to 2023 and again from February to December 22, 2025. BF Labs was suspended from trading in April 2024 after receiving a disclaimer of opinion from its auditor due to limitations in the scope of the audit and concerns regarding investment transactions. The Korea Exchange’s Corporate Review Committee approved BF Labs’ delisting in June 2025, but the process is currently on hold pending a court decision on a request for a preliminary injunction filed by the company.
The situation has led to accusations of a “parking deal,” where DHX may be acting as a vehicle to facilitate the transfer of assets from BF Labs. BF Labs, facing potential delisting, has moved to sell off assets, and the timing and structure of the DHX transaction raise questions about the true intent of the deal.
DHX has been consistently reporting losses. In 2024, the company recorded revenue of 9.5 billion won ($7.3 million USD) but a net loss of 18.3 billion won ($14.0 million USD). As of the third quarter of 2025, cumulative revenue was 11.5 billion won ($8.8 million USD) with a net loss of 10.9 billion won ($8.3 million USD). The company’s accumulated deficit stands at 74.5 billion won ($57.1 million USD) as of the end of the third quarter.
DHX did not respond to requests for comment regarding these developments.
The next key date in this unfolding situation is February 27, 2026, when Preedicom is scheduled to complete its investment in DHX. The outcome of this capital raise and the subsequent use of funds will be closely watched by investors and regulators alike. Readers can stay informed about official updates through the Korea Exchange (https://www.krx.co.kr/eng/) and DHX’s investor relations website.
This story is developing and will be updated as more information becomes available.
